BeiGene
ONC
#733
Rank
HK$206.72 B
Marketcap
HK$1,779
Share price
-0.76%
Change (1 day)
73.47%
Change (1 year)
BeiGene is a Chinese pharmaceutical company engaged in the R&D, and commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

EPS for BeiGene (ONC)

EPS in 2024 (TTM): -HK$48.67

According to BeiGene 's latest financial reports the company's current EPS (TTM) is -HK$48.42. .

EPS history for BeiGene from 2015 to 2024

Annual EPS

Year EPS Change
2024-HK$48.42
2022-HK$151.3328.21%
2021-HK$118.03-19.96%
2020-HK$147.4720.81%
2019-HK$122.0731.52%
2018-HK$92.81417.57%
2017-HK$17.93-37.16%
2016-HK$28.54158.95%
2015-HK$11.02

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-HK$7.76-83.97%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$2.10-95.67%๐Ÿ‡บ๐Ÿ‡ธ USA